Anzeige
Mehr »
Donnerstag, 18.09.2025 - Börsentäglich über 12.000 News
Die Ethereum-Vorreiter: Wie Republic Technologies die Infrastruktur der Zukunft aufbaut
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
188 Leser
Artikel bewerten:
(0)

Zilis' Exclusive Support Opens The Door For Hemp in Wyoming

ARGYLE, TX / ACCESSWIRE / March 14, 2019 / Zilis LLC®, the leader in the hemp-derived CBD oil industry through its UltraCell® product line, applauds the passing of House Bill 171 in the State of Wyoming. This bill recognizes hemp as an agricultural crop and allows the possession, purchase, sale, transportation, and use of hemp and hemp products by any person.

Lawmakers across the aisle sponsored HB171, understanding the need to diversify Wyoming's energy-dependent economy. Wyoming attorney and lobbyist Matthew Kaufman, along with his fellow ENDOW members, recognized Zilis for funding the lobbying effort. "The people of Wyoming, especially our farmers, are forever grateful to Zilis for their enormous generosity. The company is leading the way to birth an entire industry within our state and giving farmers hope they haven't had in decades," Kaufman announced after the bill's passage. Success in Wyoming is a strong precedent that will positively influence states currently crafting their own hemp bills.

As Executive Vice-President of the U.S. Hemp Round Table, Zilis CEO Steven Thompson stated, "Zilis is prepared to take on the challenges individual states may face as they seek new hemp legislation. We are fully committed to the success of our Independent Ambassadors, as well as to the entire industry." Exclusive hemp counsel to Zilis and primary author of the 2018 Farm Bill, Jonathan Miller, Esq., said, "When the call was given to the leaders in the hemp industry to help Wyoming, Zilis single-handedly funded the entire effort." Miller, widely regarded as the nation's leading authority on hemp, continued, "…that is why I exclusively represent Zilis within the direct sales industry. Through their actions and dedication, Zilis continues to prove why they are the Gold Standard in CBD." Kaufman and Wyoming had the full force of Zilis behind them to educate and promote HB171 through the Wyoming House and Senate, and finally, passage into law. The future of Wyoming industry and agriculture was changed forever when Governor Mark Gordon signed HB171 into law on March 6, 2019.

Zilis CEO Steven Thompson anticipates explosive growth in states with industrial hemp bills like Wyoming. Farmers and budding entrepreneurs alike will capitalize upon that growth generating a robust marketplace that supports the overall economic success of each state.

About Zilis LLC

Zilis®, is the creator of UltraCell®, a CBD oil product derived from hemp. With independent direct sales ambassadors throughout the country, Zilis has been at the forefront of the movement to harness the power of hemp, and specifically its CBD oil, which is used by tens of thousands throughout the world as a dietary supplement. Based in Argyle, Texas, a suburb of Dallas-Fort Worth, Zilis is privately held. Zilis and its ambassadors are committed to giving back through the "Pay It Forward" nutrition program. Since 2015, the company has donated tens of millions of days' worth of vitamin supplements to young children and pregnant women in all 50 states and the developing world. Visit https://zilis.com for more information.

Product Disclaimer

Zilis products have not been evaluated by the Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent any disease or medical conditions. The information on the Zilis website, marketing materials, product labels or packaging is not intended as medical advice and should not substitute advice from a healthcare professional. Please consult with your physician or other healthcare provider if you have health-related questions before using any of our products or relying on any information you obtain from the Zilis website. You should discuss any medications or nutritional supplements you are using with a healthcare provider before using any new medications or supplements. Always review the labels, warnings, and directions included with your product before using or consuming the product and do not rely solely on the information shown on the Zilis website.

CONTACT:

Scott Adams
940-535-7200
scott.adams@zilis.com

SOURCE: Zilis LLC



View source version on accesswire.com:
https://www.accesswire.com/539074/Zilis-Exclusive-Support-Opens-The-Door-For-Hemp-in-Wyoming

© 2019 ACCESS Newswire
Epische Goldpreisrallye
Der Goldpreis hat ein neues Rekordhoch überschritten. Die Marke von 3.500 US-Dollar ist gefallen, und selbst 4.000 US-Dollar erscheinen nur noch als Zwischenziel.

Die Rallye wird von mehreren Faktoren gleichzeitig getrieben:
  • · massive Käufe durch Noten- und Zentralbanken
  • · Kapitalflucht in sichere Häfen
  • · hohe Nachfrage nach physisch besicherten Gold-ETFs
  • · geopolitische Unsicherheit und Inflationssorgen

Die Aktienkurse vieler Goldproduzenten und Explorer sind in den vergangenen Wochen regelrecht explodiert.

Doch es gibt noch Titel, die Nachholpotenzial besitzen. In unserem kostenlosen Spezialreport erfahren Sie, welche 3 Goldaktien jetzt besonders aussichtsreich sind und warum der Aufwärtstrend noch lange nicht vorbei sein dürfte.

Laden Sie jetzt den Spezialreport kostenlos herunter und profitieren Sie von der historischen Gold-Hausse.

Dieses Angebot gilt nur für kurze Zeit – also nicht zögern, jetzt sichern!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.